# Crown Holdings (CCK) — Financial Analysis

**Exchange:**   
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-12  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/CCK/thesis · /stocks/CCK/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: CCK
step: 04
title: Financial Quality & Adversarial Research Sweep
date: 2026-06-11
---

### Step 04 — Financial Quality: Crown Holdings (CCK)

#### Statement Quality Overview

Crown Holdings' financial statements are prepared under US GAAP with consistent accounting policies. The company is a mature, large-cap industrial with established auditors (PricewaterhouseCoopers LLP) and Big 4 audit coverage. No material restatements, SEC inquiries, or going-concern issues were identified in the filing review. [S3]

**Key Quality Observation:** CCK's GAAP results include significant non-operating items that obscure true operating performance:
1. **Pension settlement charges** — Q3 2024 recorded large charges for partial U.S. pension plan settlement, driving reported net income to -$175M in Q3 2024.
2. **Goodwill impairments** — FY2021 reported $560M net loss primarily from goodwill impairment charges.
3. **One-time tax items** — FY2024 included $64M U.S. tax charge related to Eviosys distribution.
4. **Intangibles amortization** — Related primarily to Signode acquisition; excluded from segment income.

Adjusted EPS (management's preferred metric) strips these items: FY2025 Adj. EPS of $7.79 vs. GAAP EPS of $6.38. [S4]

---

#### Income Statement Quality

##### Revenue Recognition
Crown Holdings recognizes revenue when control of products is transferred to the customer (ASC 606). The pass-through nature of aluminum pricing means reported revenue fluctuates with commodity prices even if underlying volumes and conversion margins are stable. This is structural accounting behavior, not manipulation. [S2]

##### Segment Income Definition
Segment income is a non-GAAP metric: GAAP operating income adjusted to exclude:
- Intangible amortization (primarily Signode purchase price allocation)
- Restructuring charges
- Fair value adjustments on acquired inventory

This is consistent with how packaging peers report segment profitability and provides a better view of ongoing conversion margin. [S2]

##### SBC (Stock-Based Compensation)
SBC has risen from $29M (FY2022) to $48M (FY2025). As a percentage of revenue, SBC is ~0.4% — immaterial and within normal range for a capital-intensive industrial. Not a quality concern. [S1]

##### Effective Tax Rate
- FY2024: 24.6%
- FY2023: 27.9%
- FY2022: 23.0%

Tax rate is volatile year-to-year due to geographic profit mix and non-recurring items (FY2024 Eviosys tax charge, FY2024 pension-related tax benefit). Normalized rate is approximately 25–27%. [S2]

---

#### Balance Sheet Quality

##### Working Capital
- Current ratio: 1.22x (FY2024), 1.03x (FY2025)
- Quick ratio: 0.74x (FY2024), 0.59x (FY2025)

Working capital is tight but adequate for a capital-intensive industrial that runs with minimal excess cash. Q1 is seasonally negative for OCF due to working capital build (inventory). [S4]

##### Goodwill and Intangibles
The Signode acquisition ($3.9B in 2018) created significant goodwill and intangibles. FY2021 included a goodwill impairment charge — a signal that the acquisition was overpriced or that Signode's value was lower than expected. Current goodwill balance is not broken out precisely in available data, but implied from the total assets structure. This is a watch item if Signode performance continues to disappoint. [S2]

##### Pension Obligations
CCK has significant defined benefit pension obligations. In Q3 2024, the company executed a partial U.S. pension plan settlement (transferring obligations to an insurance carrier), recording a large non-cash charge. The remaining pension obligations are estimated but have been partially derisked through this settlement. Future pension contributions will be lower. [S2]

##### Receivables Securitization
CCK operates receivables securitization facilities (U.S. $800M program, expired July 2025; additional facilities totaling ~$390M, expired Nov 2025). These were off-balance-sheet financing tools that reduce reported working capital needs. Expiry of these facilities in mid-2025 may have modestly increased reported gross receivables. [S2]

---

#### Cash Flow Statement Quality

##### OCF-to-Net Income Conversion
| Year | Net Income | OCF | Conversion Ratio |
|------|-----------|-----|-----------------|
| 2025 | $738M | $1,530M | 2.07x |
| 2024 | $424M | $1,192M | 2.81x |
| 2023 | $450M | $1,453M | 3.23x |
| 2022 | $727M | $803M | 1.10x |

High OCF/NI ratios in 2023–2025 reflect (1) high D&A relative to CapEx, (2) non-cash items (pension charges, goodwill), and (3) working capital cycling. The ~2x+ conversion is expected for a capital-intensive industrial with these D&A levels. No quality concern. [S1]

##### CapEx Normalization
The step-down from $839M (2022) to $403M (2024) to $413M (2025) is the core FCF inflection story. This is genuine — major greenfield projects in Virginia, Nevada, Brazil, and UK are mechanically complete. The FY2026 guidance of ~$550M is slightly elevated (India greenfield investment beginning) but still materially below peak. [S2]

---

#### Adversarial Research Sweep

*Note: This analysis is based on filings, press releases, and public court records. No earnings call transcripts were reviewed (coverage-next-full path). No short-seller or activist reports were identified targeting CCK specifically.*

##### Claim 1: Asbestos Liability — Is It Bounded?
**Bear claim:** Crown Cork & Seal (a predecessor entity) acquired a portion of Mundet Cork Corporation in 1963, which manufactured asbestos-containing products. Plaintiffs have alleged Crown Holdings (as successor) is liable for decades of asbestos exposure claims.

**Assessment:** The key protection is Pennsylvania statute 42 Pa.C.S. §5303, which specifically caps Crown Cork's liability to claims where the plaintiff had actual occupational contact with Crown Cork's asbestos products. This statute has survived repeated legal challenges. CCK consistently settles hundreds of claims annually at a bounded level. Annual asbestos settlement costs are typically $60–100M/year based on historical filings. The risk is not zero — federal legislation could preempt the PA statute — but current trajectory suggests this is a manageable, recurring cost, not an existential liability. [S2] **Fact vs. Judgment: Judgment (PA statute durability)**

##### Claim 2: Signode Acquisition — Was It a Value Destroyer?
**Bear claim:** CCK paid ~$3.9B for Signode in 2018 at a peak industrial valuation. Signode revenue has declined from $2,545M (2022) to $2,107M (2024). Goodwill impairment in FY2021 validates the bear case.

**Assessment:** The FY2021 impairment charge confirms that Signode was overvalued at acquisition, at least temporarily. However, Signode still generates $270M+ of segment income annually at a ~12.8% margin, creating meaningful FCF. The question is whether Signode is worth its ~$2.5–3.0B implied enterprise value today. If CCK were to sell/spin Signode, the remaining pure-play beverage can business would likely re-rate significantly higher (closer to Ball's multiple). This is a legitimate bear/catalyst thesis. [S2, S4] **Fact vs. Judgment: Mixed**

##### Claim 3: BPA Regulatory Risk
**Bear claim:** CCK's can coatings historically used bisphenol-A (BPA), a chemical facing regulatory scrutiny globally (EU classification as SVoC, potential U.S. FDA action).

**Assessment:** CCK (and the broader industry) has been transitioning to BPA-free coatings since 2018. The 2024 10-K still mentions BPA as a risk factor but notes the transition is ongoing. This is a legitimate tail risk but not a near-term earnings threat. The industry has a multi-year track record of managing BPA regulatory transitions without major disruption. [S2] **Fact: Disclosed risk factor**

##### Claim 4: European Overcapacity Risk
**Bear claim:** Canpack's aggressive greenfield buildout in Europe (and now the U.S.) could reprice the European beverage can market, compressing CCK's recovering European margins.

**Assessment:** This is the most credible medium-term risk. Canpack has opened multiple EU plants since 2021 and is reportedly building its first U.S. facility. Excess capacity in regional markets creates pricing pressure. CCK's European margin recovery from 5.8% to 13.3% could stall or reverse if Canpack disrupts pricing. The bull counter-argument: Canpack is building to serve long-term contracts, not to reprice the market; European can demand growth (5%+ p.a.) should absorb new capacity. **Fact vs. Judgment: Judgment — key thesis risk**

##### No Material Red Flags Found
- No SEC enforcement actions or formal investigations
- No recent shareholder derivative lawsuits of significance
- No activist campaigns targeting CCK (as of June 2026)
- No forensic accounting flags (channel stuffing, revenue pull-forward) in the available data

---

#### Financial Quality Summary

| Dimension | Assessment | Note |
|-----------|-----------|------|
| Revenue recognition | Clean | Pass-through mechanics clearly disclosed |
| GAAP vs. adjusted gaps | Moderate | Pension + goodwill + intangibles amortization distort GAAP; adjusted metrics are more representative |
| Cash conversion | High | OCF consistently exceeds net income |
| CapEx guidance accuracy | High | FY2024 actual $403M vs. guidance ~$400–450M |
| Debt transparency | Adequate | Detailed debt schedule in 10-K; off-balance-sheet structures (A/R securitization) disclosed |
| Auditor | PwC — Clean opinions | No material weaknesses noted |
| Asbestos liability | Bounded but real | PA statute protective; annual cost manageable |
| Goodwill/Impairment risk | Moderate | Signode impairment risk if revenue/margin decline resumes |

---

#### Source Index

| Code | Source |
|------|--------|
| S1 | SEC EDGAR XBRL — `xbrl/xbrl_summary.md` |
| S2 | Crown Holdings 10-K FY2024 — `sec_filings/10K_FY2024_summary.md` |
| S3 | Filing inventory — `sec_filings/filing_inventory.md` |
| S4 | StockAnalysis.com — `other/stockanalysis_summary.md` |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/CCK/fundamental

## Navigation

- Overview: /stocks/CCK
- Financials (this page): /stocks/CCK/financials
- Thesis: /stocks/CCK/thesis
- Investment Memo: /stocks/CCK/memo
- Coverage universe: /stocks